©2020 by HALO Diagnostics

PROSTATE CANCER DIAGNOSIS AND INTERVENTION

Personalized and Informed Decisions to Plan Your Treatment

Desert Medical Imaging has been a leader in medical imaging services since 1998 and will continue to lead the charge in early detection of prostate cancer as Halo Diagnostics' global center for innovation.

 

Diagnosis: Precision and Timely Intervention

We believe in early, precise diagnosis of prostate cancer and timely surveillance for prostate cancer patients post-treatment. At our Desert Medical Imaging (DMI) Center, we provide non-invasive,  targeted multiparametric MRI (mpMRI) services before performing a biopsy. 


Magnetic resonance imaging (MRI) is a non-invasive imaging technology.

Multiparametric MRI (mpMRI)  is a recent advancement in the diagnosis and management of prostate cancer. As the name suggests it uses multiple MRI sequences to look at the prostate.

Combined together with the serum prostate-specific antigen (PSA) tests, it is very effective in early detection, monitoring, and management of prostate cancer. This means it will benefit men who go undiagnosed and remain under active surveillance or watchful waiting, without timely appropriate treatment. 

Find out if mpMRI is a good option for you!

 

FOR MORE INFORMATION

We are always here for you! Contact us to schedule an appointment or to talk to one of our clinicians.
EMAIL at contact@halodx.com

 

MRI-GUIDED BIOPSY

Imaging-guided Precision in Diagnosis

Image-guided biopsy focused on tumor suspicious region. Minimally invasive and elemental for treatment decisions. 

Real-time monitoring provides precision in prostate biopsy.

This is a highly specific image-targeted biopsy technique, mpMRI aids in real-time detection of the tumor suspicious region prior to the biopsy and then a needle is used to sample only the suspicious area within the gland, sparing healthy tissue.

Unlike the conventional blind approach in transrectal ultrasound-guided biopsy (TRUS), where biopsy cores are taken randomly without seeing the tumor within the prostate gland.

CALL US (833) 464-4256

 

LASER FOCAL THERAPY (LITT OR FLA)

Investigational Therapy

Imaging-guided Precision in Diagnostics

Imaging-guided biopsy focused on tumor suspicious region. Minimally invasive and elemental for treatment decisions. 

Real-time monitoring provides precision in prostate biopsy.

This is a highly specific image-targeted biopsy technique, mpMRI aids in real-time detection of the tumor suspicious region prior to the biopsy and then a needle is used to sample only the suspicious area within the gland, sparing healthy tissue.

Unlike the conventional blind approach in transrectal ultrasound-guided biopsy (TRUS), where biopsy cores are taken randomly without seeing the tumor within the prostate gland.

CALL US (833) 464-4256

 

mpMRI Policy Update

 AUA updates policy statement on mpMRI for prostate cancer

There are important changes for urologists to note in the newly published update of the AUA’s policy statement on multiparametric magnetic resonance imaging (MRI) for diagnosing, staging and managing prostate cancer, according to policy statement co-author Marc A. Bjurlin

This update to the original statement, published October 2017, is now endorsed by both the AUA and the Society of Abdominal Radiology, according to Dr. Bjurlin, of Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.

In essence, research supports use of a quality prostate MRI before an initial biopsy in men at risk of harboring prostate cancer and in men with a rising PSA after an initial negative standard prostate biopsy, the expert panel wrote.

NEWS CREDIT

 

MEET OUR SPECIALISTS

Our Team of Qualified Health Care Providers

DR. JOHN FELLER

Chief Medical Officer, Halo Dx
Board Certified Diagnostic Radiologist
In a first in the world outpatient facility recent innovation, Dr. Feller developed a prostate cancer detection and treatment program which uses MRI to guide biopsies of the prostate and MR-guided Focal Laser Ablation to detect and remove tumors on an outpatient basis, offers patients safe treatment with less recovery time and excellent outcomes.

 

FREQUENTLY ASKED QUESTIONS

HOW DO I DECIDE IF MPMRI IS A GOOD OPTION FOR ME?

mpMRI may be a good option for you if you have 
A. Clinical suspicion of prostate cancer 
Prostate-specific antigen (PSA) levels in the blood >4 ng/ml, abnormal digital rectal exam, and no prior history of prostate biopsy
Active surveillance in patients with Gleason score 6 or grade group 1 and PSA <10 ng/ml
B. Managing prostate cancer in patients post-treatment
Monitoring patients with biochemical recurrence of prostate cancer following treatment (prostatectomy or radiation)

WHAT ARE THE ADVANTAGES OF IMAGING-GUIDED BIOPSY OVER CONVENTIONAL TRUS BIOPSY?

Imaging-guided biopsy has the following advantages 
The MRI-guided biopsy is specific targeting of tumor suspicious region instead of random sampling (TRUS biopsy can miss aggressive cancer lesions about 30-35% of the time)
Minimally invasive with fewer cores (3-4) instead of 12 core TRUS Bx
Reduced chances of infection
Increased sensitivity of detecting aggressive lesions with decreased potential for detecting indolent disease.  This reduces overtreatment and prevents the psychological burden with misclassification of cancer stage

WHAT SHOULD I EXPECT BEFORE THE (MR-GUIDED) BIOPSY PROCEDURE?

Most patients visiting the clinic are concerned about the actual procedure and what it entails. 
At DMI we believe in providing care with advanced technology. 
Patients can request a consultation with one of our expert clinicians to address questions and uncertainties around the procedure. 
Prior to the procedure, they are also provided an informed consent form that details the risks and benefits. 
Patients are recommended to discontinue anticoagulants at least five days before the biopsy. 
Antibiotics are administered during the biopsy to avoid any infection or inflammation. We use numbing jelly to make sure the patients have an overall comfortable experience.

DO YOU OFFER FREE HEALTH CONSULTATIONS?

Yes, our health experts are available to provide free consultation and answer your questions prior to the procedures. Contact our experts TODAY!

WHAT IS GLEASON SCORE?

Gleason score is an indicator of prostate cancer condition - higher scores mean more aggressive cellular architecture (think of golf scores!).

It is the sum of two numbers, Primary Gleason Grade and Secondary Gleason Grade, ranging from 1-5 that indicate the pathology of the cells in the tumor. A lower number indicates that the biopsy is closer to normal tissue and vice versa. 


The Gleason Scores (sum of Grades) range between 6-10 and describe the aggressiveness of the disease. Higher scores (8 and above) predict that cancers might grow and/or spread quickly. A Gleason score 7 (4+3/ 3+4) suggests intermediate risk with 4+3 being at a higher risk of progression than 3+4 (as the 4 pattern is dominant).

WHAT IS THE DIFFERENCE BETWEEN 1.5T AND 3T MRI SCANNERS? ARE 3T SCANNERS A BETTER OPTION FOR PROSTATE MRI?

When clinicians refer to MRI scanners as 1.5 T or 3T they are referring to the magnetic field strength of the scanner. Tesla (T) is the unit of measure of the magnetic flux density. Most commonly used scanners are 1.5 T or 3T, although recently higher strength magnets such as 7T scanners have also been developed. 
Although higher magnetic field strength (3T) imaging may mean higher resolution images, it also means more potential for noise and artifacts. 
Metal implants and 3T imaging: 3T scanner is not practical for individuals with metal implants and devices as high magnetic fields can lead to malfunction of some implanted devices.  Orthopedic implants may also cause large artifacts, rendering the scan non-diagnostic.
Overheating hazards: There are potential issues with overheating at high field strengths (specific absorption rate of radiofrequency energy or SAR).